Search Press releases Keywords From To 18 Oct 2019 EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture Read More 17 Oct 2019 Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly Greater Efficacy Versus Placebo and Ustekinumab Read More 11 Oct 2019 Transparency notification BlackRock, Inc. Read More 10 Oct 2019 UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with myasthenia gravis and other rare diseases Read More 9 Oct 2019 UCB Showcases Wealth of new Psoriasis Research at EADV 2019 Read More 8 Oct 2019 Transparency notification Wellington Read More Pagination First page Previous page Previous … Page 54 Page 55 Page 56 Page 57 Current page 58 Page 59 Page 60 Page 61 Page 62 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
